Bi
Biomea Fusion Inc
BMEA · NASDAQ4.12
Bi
4.12
USD-0.04-0.96%Latest News
#earnings summary for the week ended March 31, 2023 https://t.co/1pgojKC5HH $LOCL $BCLI $BMEA $YMAB $SCYX $ALIM $ARC $NOTE $AXDX $EVGO $KC $GMDA $ANGO $SMTC $EGY $CCL $CXM $SFT $MU $THRN $CURI $BNTX $XOS $UGRO $PIII $KINS $EDAP $PEGY $ACRX $DPSI $ADN $PNT $MANU $PRPH $IDXG… https://t.co/qqAqOEWYYI
Day Range
4.01USD
4.27USD
52 Week Range
3.61USD
20.21USD
Market Cap
150.39MUSD
About
General Information
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09077A1060
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
2.10
Dividend Share
-
Dividend Yield
-
Earnings Share
-4.01
Wall Street Target Price
28.1111
EPS Estimate Current Year
-3.8762
EPS Estimate Next Year
-3.0474
EPS Estimate Current Quarter
-0.95
EPS Estimate Next Quarter
-0.9
Most Recent Quarter
-
Profitability
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-149,624,992
Profit Margin
0.00%
Return On Assets TTM
-56.38%
Return On Equity TTM
-104.51%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-4.01
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
1.9796
Enterprise Value Revenue
0
Enterprise Value EBITDA
-3
Peers analysis
- CMXHFCSL Limited
169.54
3.19% - BNTXBioNTech SE
115.15
2.57% - VRTXVertex Pharmaceuticals Inc
418.34
1.62% - REGNRegeneron Pharmaceuticals Inc
698.00
1.06% - CSLLYCSL Ltd
86.83
0.51%
- ALNYAlnylam Pharmaceuticals Inc
241.09
0.27% - ARGNFargenx SE
655.00
0.00% - UCBJFUCB SA
194.85
0.00% - ARGXargenx NV ADR
661.50
-0.63% - UCBJYUCB SA ADR
97.63
-0.27%
What are you waiting for?Start making profit today
©
2025
All rights reserved